No reimbursed personal expenses reported for March, 2023
$0.00
Employer | Amount |
---|---|
Prime Therapeutics, LLC | 2190.00 |
No payments to sub-contracted lobbyists reported for March, 2023
No itemized entertainment expenses reported for March, 2023
No non-itemized entertainment expenses reported for March, 2023
No itemized contributions by employer reported for March, 2023
No itemized contributions by employer's PAC reported for March, 2023
No other itemized contributions reported for March, 2023
No non-itemized contributions by employer reported for March, 2023
0.00
No PAC contribution activity reported for March, 2023
No advertising expenses reported for March, 2023
No political advertising expenses reported for March, 2023
No other lobbying expenses reported for March, 2023
Employer | Subject Matter of Proposed Legislation | Issue or bill number | Persons, Legislative committee or State Agency considering the matter |
---|---|---|---|
Prime Therapeutics, LLC | Health Care | SB 5066 | House Committee on Health Care and Wellness; Appropriations Committee |
Prime Therapeutics, LLC | Health Care | HB 1357 | Senate Health and Long Term Care Committee; Ways and Means Committee |
Prime Therapeutics, LLC | Health Care | SB 5213 | Senate Rules Committee |
Prime Therapeutics, LLC | Health Care | SB 5445 | Senate Health and Long Term Care Committee |
Prime Therapeutics, LLC | Health Care | HB 1465 | House Health Care and Wellness Committee |
Prime Therapeutics, LLC | Health Care | HB 1253 | House Health Care & Wellness Committee |
Prime Therapeutics, LLC | Health Care | Cost of Insulin workgroup | Washington State Health Care Authority |
50.00%
Percent of time spent lobbying state agencies.50.00%